首页 | 本学科首页   官方微博 | 高级检索  
检索        

罗哌卡因蛛网膜下腔阻滞的研究进展
引用本文:张研,胡允梅,屠伟峰.罗哌卡因蛛网膜下腔阻滞的研究进展[J].国际麻醉学与复苏杂志,2007,28(1):54-55,58.
作者姓名:张研  胡允梅  屠伟峰
作者单位:1. 518033,深圳市中医院麻醉科
2. 广州军区总医院全军临床麻醉中心
摘    要:罗哌卡因是第一个纯左旋异构体局麻药,1999年被引进我国,目前在我国多用于外周神经阻滞和硬膜外腔阻滞麻醉,但是在国外已是官方认证的蛛网膜下腔阻滞用药,且自引入我国以来就不断有学者进行了罗哌卡因蛛网膜下腔阻滞的动物实验和临床研究,现就国内外罗哌卡因用于蛛网膜下腔阻滞的研究情况作一综述。

关 键 词:罗哌卡因  蛛网膜下腔阻滞

Advance in study of ropivacaine spinal block
ZHANG Yan,HU Yun-mei,TU Wei-feng.Advance in study of ropivacaine spinal block[J].international journal of anesthesiology and resuscitation,2007,28(1):54-55,58.
Authors:ZHANG Yan  HU Yun-mei  TU Wei-feng
Institution:Department of Anesthesia, Traditional Chinese Medical Hospital of Shenzhen, Shenzhen 518033, China
Abstract:Ropivaeaine is the first local anesthetic agent as pure(S)-isomer.It is now being used mainly for nerve block and epidural block after introduced into China in 1999.However,ropivacaine has been applied for spinal block with foreign official approv- al,and animal and clinical studies for spinal block are also conducted in our country.This review summarizes the recent advance in study of ropivacaine spinal block.
Keywords:ropivacaine  spinal block
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号